ALTS: JanOne Inc. Stock

by  •  • Comments Off on ALTS: JanOne Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 92.97
Enterprise Value ($M) 124.38
Book Value ($M) 28.67
Book Value / Share 1.86
Price / Book 3.24
NCAV ($M) -18.77
NCAV / Share -1.22
Price / NCAV -4.95

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.34
Return on Equity (ROE) -0.82

Liquidity (mrq)
Quick Ratio 0.85
Current Ratio 0.85

Balance Sheet (mrq) ($M)
Current Assets 35.00
Assets 82.44
Liabilities 53.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 12.53
Operating Income -7.56
Net Income -6.25
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 1.78
Cash from Investing 5.85
Cash from Financing 6.09

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2025-03-25 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 19,229 70,836 27.15
2025-05-08 31,431 108,640 28.93
2025-05-07 16,937 82,324 20.57
2025-05-06 14,908 77,206 19.31
2025-05-05 23,417 116,245 20.14

(click for more detail)

Similar Companies
AKBA – Akebia Therapeutics, Inc. ALDX – Aldeyra Therapeutics, Inc.
ALGS – Aligos Therapeutics, Inc. ALZN – Alzamend Neuro, Inc.
ANEB – Anebulo Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io